(Q33885487)

English

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Hausdorff WP

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Bryant J

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kloek C

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paradiso PR

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Siber GR

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

122-140

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

The enduring pneumococcus: unfinished business and opportunities for the future

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Epidemiology of invasive pneumococcal infections in children in Finland

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Serotypes and antibiotic susceptibilities of Streptococcus pneumoniae in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Pneumococcal and Haemophilus influenzae meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Pneumococci causing invasive disease in Britain 1982-1990.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Pneumococcal meningitis in children: prognostic indicators and outcome

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Prevention of otitis media in children by pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand

1 reference

https://api.crossref.org/works/10.1086%2F313609

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33885487&oldid=1609807335"